Tipepidine Hibenzate

DRUG3 trials

Sponsors

Chiba University

Conditions

AdolescentAttention Deficit Disorder With HyperactivityAttention Deficit Disorder With Hyperactivity DiseaseAttention Deficit and Disruptive Behavior DisordersDepressionHyperkinesis

Phase 1

Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

CompletedNCT02305134

Chiba UniversityAttention Deficit and Disruptive Behavior Disorders, Attention Deficit Disorder With Hyperactivity Disease, Hyperkinesis

Start: 2015-06-11End: 2019-03-31Updated: 2019-03-19

Phase 2

An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD)

CompletedNCT01835093

Chiba UniversityAttention Deficit Disorder With Hyperactivity

Start: 2013-04-30End: 2014-02-28Updated: 2014-02-21

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

CompletedNCT01835847

Chiba UniversityAdolescent, Depression

Start: 2013-04-30End: 2014-03-31Updated: 2014-05-23